Login to Your Account


FDA 'INTERCHANGE' TRAFFIC DUE?

Celltrion Healthcare Inc. planted the oncology flag in biosimilars with the European Commission's approval of Truxima, a biosimilar to Rituxan (rituximab, Roche Holding AG/Biogen Inc.).

more »


Opinion


Partners in Focus